Viewing Study NCT02832804


Ignite Creation Date: 2025-12-24 @ 9:11 PM
Ignite Modification Date: 2026-02-25 @ 11:09 PM
Study NCT ID: NCT02832804
Status: COMPLETED
Last Update Posted: 2021-09-24
First Post: 2016-04-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Effect of Transcranial Direct-current Stimulation Therapy on Primary Chronic Insomnia Patients
Sponsor: Seoul National University Hospital
Organization:

Study Overview

Official Title: Effect of Transcranial Direct-current Stimulation Therapy on Primary Chronic Insomnia Patients: A Pilot Study.Insomnia Patients
Status: COMPLETED
Status Verified Date: 2021-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: To evaluate the clinical efficacy and safety of neuromodulation by transcranial direct current stimulation (tDCS) in the patients with primary chronic insomnia .
Detailed Description: * visit 1

* to fill in a questionnaire (Clinical Global Impression, CGI; Leeds Sleep Evaluation Questionnaire, LSEQ; Stanford Sleepiness Scale, SSS; Hospital Anxiety and Depression Scale, HADS; 36-Item Short Form Survey, SF-36)
* EEG
* visit 2-6

* tDCS stimulation (monday \~ friday)
* anodal / cathodal / sham
* to fill in a questionnaire (CGI, LSEQ, SSS, HADS)
* analysis the results of sleep log and actigraphy
* visit 7 : 1 week after treatment

* to fill in a questionnaire (CGI, LSEQ, SSS, HADS)
* analysis the results of sleep log and actigraphy
* EEG
* visit 8 : 1 month after treatment

* to fill in a questionnaire (CGI, LSEQ, SSS, HADS, SF-36)
* analysis the results of sleep log

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: